Achaogen Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$3.97 |
Market Cap |
$216.55 M |
Shares Outstanding |
45.21 M |
Public Float |
24.99 M |
Address |
1 Tower Place South San Francisco California 94080 United States |
Employees | - |
Website | http://www.achaogen.com |
Updated | 09/14/2018 |
Achaogen, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections. It offers Plazomicin to treat bacterial illness, such as complicated urinary tract infection, blood stream infections, and other infections due to MDR Enterobacteriaceae. The company was founded by Nathaniel E. |